Lobbying

Huvepharma's latest lobbying report covers Q1 2023, at $30K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.

Huvepharma

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Huvepharma lobbying by quarter
Huvepharma lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$30K1
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Budget and appropriations$25K · 1 reports
  • Health issues$25K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES1 reports
  • SENATE1 reports

Firms it paid

Firm
Williams and Jensen, PLLC$80K2 quarters

Former officials lobbying for it

Former position
JAMES B BURCHFIELDStaff Associate, House Foreign Affairs Committee; Professional Staff Member, House Committee on Small Business; Senior Policy Advisor, Congressman Steve ChabotQ4 2022

Lobbying reports

Filed by
23/04/19for Q1 2023Williams and Jensen, PLLC$30K
23/01/20for Q4 2022Williams and Jensen, PLLC$50K